HighVista Strategies LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$2,065,828
-21.9%
39,804
-9.7%
0.96%
-21.0%
Q2 2023$2,643,876
+305.3%
44,094
+234.2%
1.21%
+127.9%
Q1 2023$652,311
-13.4%
13,1940.0%0.53%
+18.8%
Q4 2022$752,982
-3.3%
13,194
-20.5%
0.45%
+0.4%
Q3 2022$779,00016,5880.44%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$29,942,30435.70%
RTW INVESTMENTS, LP 6,096,387$316,402,4856.68%
Paradigm Biocapital Advisors LP 1,384,686$71,865,2034.88%
Rock Springs Capital Management LP 2,943,710$152,778,5494.09%
Logos Global Management LP 450,000$23,355,0003.12%
TANG CAPITAL MANAGEMENT LLC 405,600$21,050,6402.97%
GREAT POINT PARTNERS LLC 290,917$15,098,5922.75%
Nicholas Investment Partners, LP 512,855$26,617,1751.99%
Eschler Asset Management LLP 30,000$1,557,0001.82%
COWEN AND COMPANY, LLC 460,036$23,875,8681.67%
View complete list of IMMUNOCORE HLDGS PLC shareholders